Acute Myeloid Leukemia with Genetic Abnormalities

Acute Myeloid Leukemia with Genetic Abnormalities — Research · CancerIndex

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

pubmedComputed14 windows · counts computed by CancerIndex from PubMed E-utilities; the exact query is stored with each count.

Window	Period	Exact query	Computed	Source
All time	… → 2026-09-30	`("Acute Myeloid Leukemia with Genetic Abnormalities"[tiab] OR "AML with Genetic Abnormalities"[tiab])`	2026-09-30	pubmed
Last 5 years	2021-01-01 → 2026-12-31	`("Acute Myeloid Leukemia with Genetic Abnormalities"[tiab] OR "AML with Genetic Abnormalities"[tiab]) AND (2021/01/01:2026/12/31[dp])`	2026-09-30	pubmed
Preceding 5-year window	2020-09-30 → 2025-09-29	`("Acute Myeloid Leukemia with Genetic Abnormalities"[tiab] OR "AML with Genetic Abnormalities"[tiab]) AND (2020/09/30:2025/09/29[dp])`	2026-09-30	pubmed
Last 12 months	2025-09-30 → 2026-09-30	`("Acute Myeloid Leukemia with Genetic Abnormalities"[tiab] OR "AML with Genetic Abnormalities"[tiab]) AND (2025/09/30:2026/09/30[dp])`	2026-09-30	pubmed
y2016	2016-01-01 → 2016-12-31	`("Acute Myeloid Leukemia with Genetic Abnormalities"[tiab] OR "AML with Genetic Abnormalities"[tiab]) AND (2016/01/01:2016/12/31[dp])`	2026-09-30	pubmed
y2017	2017-01-01 → 2017-12-31	`("Acute Myeloid Leukemia with Genetic Abnormalities"[tiab] OR "AML with Genetic Abnormalities"[tiab]) AND (2017/01/01:2017/12/31[dp])`	2026-09-30	pubmed
y2018	2018-01-01 → 2018-12-31	`("Acute Myeloid Leukemia with Genetic Abnormalities"[tiab] OR "AML with Genetic Abnormalities"[tiab]) AND (2018/01/01:2018/12/31[dp])`	2026-09-30	pubmed
y2019	2019-01-01 → 2019-12-31	`("Acute Myeloid Leukemia with Genetic Abnormalities"[tiab] OR "AML with Genetic Abnormalities"[tiab]) AND (2019/01/01:2019/12/31[dp])`	2026-09-30	pubmed
y2020	2020-01-01 → 2020-12-31	`("Acute Myeloid Leukemia with Genetic Abnormalities"[tiab] OR "AML with Genetic Abnormalities"[tiab]) AND (2020/01/01:2020/12/31[dp])`	2026-09-30	pubmed
y2021	2021-01-01 → 2021-12-31	`("Acute Myeloid Leukemia with Genetic Abnormalities"[tiab] OR "AML with Genetic Abnormalities"[tiab]) AND (2021/01/01:2021/12/31[dp])`	2026-09-30	pubmed
y2022	2022-01-01 → 2022-12-31	`("Acute Myeloid Leukemia with Genetic Abnormalities"[tiab] OR "AML with Genetic Abnormalities"[tiab]) AND (2022/01/01:2022/12/31[dp])`	2026-09-30	pubmed
y2023	2023-01-01 → 2023-12-31	`("Acute Myeloid Leukemia with Genetic Abnormalities"[tiab] OR "AML with Genetic Abnormalities"[tiab]) AND (2023/01/01:2023/12/31[dp])`	2026-09-30	pubmed
y2024	2024-01-01 → 2024-12-31	`("Acute Myeloid Leukemia with Genetic Abnormalities"[tiab] OR "AML with Genetic Abnormalities"[tiab]) AND (2024/01/01:2024/12/31[dp])`	2026-09-30	pubmed
y2025	2025-01-01 → 2025-12-31	`("Acute Myeloid Leukemia with Genetic Abnormalities"[tiab] OR "AML with Genetic Abnormalities"[tiab]) AND (2025/01/01:2025/12/31[dp])`	2026-09-30	pubmed

Data updated 20 hours agoSource updated unknownsource: pubmed E-utilities

Literature

Linked publications (51)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 1–25 of 51 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes.
· Blood · 2009 · PMID 19357394 · validated civic_curation pubmed
The PML/RAR alpha fusion gene in the diagnosis and monitoring of acute promyelocytic leukemia.
· Haematologica · 1995 · PMID 7628753 · validated civic_curation pubmed
All trans retinoic acid in acute promyelocytic leukemia.
· Oncogene · 2001 · PMID 11704842 · validated civic_curation pubmed
The importance of diagnostic cytogenetics on outcome in AML: analysis of 1,612 patients entered into the MRC AML 10 trial. The Medical Research Council Adult and Children's Leukaemia Working Parties.